Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
12 Combinatorial approaches involving DDR inhibitors, epigenetic modulators, metabolic disruptors and immunotherapeutics hold promise for overcoming resistance and achieving durable clinical responses across malignancies
Furthermore, its unique structure gives scientists the opportunity to conduct various studies
Biological Psychiatry
Nanotechnology has become widely used in most medical disciplines, with nanomaterials being used as antimicrobial, cancer-fighting, or loaded with biologically active drugs/compounds that improve their solubility, stability, performance, and transport to the human body (Alkhursani et al., 2022
Knocking down ACTL6A also decreased the GCLC protein expression level in GC cells (Supplementary Fig 5c)
10.1073/pnas.1309781110 Summary Keywords angiotensin IV, peptidemimetics, aminopeptidase N, cystinyl aminopeptidase, insulin-regulated aminopeptidase Citation Hallberg M and Larhed M (2020) From Angiotensin IV to Small Peptidemimetics Inhibiting Insulin-Regulated Aminopeptidase
US$ 23.23
US$ 21.91
US$ 24.87
US$ 23.39
